| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.09 | 0.05 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.047 | 0.3 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.035 | 0.4 |